Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families Sobi's head office is located at the Karolinska Institutet Science Park in Solna, Stockholm, Sweden Our late stage pipeline includes three pivotal phase III programs within hemophilia and neonatology